The Bladder Utility Symptom Scale (BUSS): A Novel Patient-Reported Outcome Instrument in Bladder Cancer.
J Urol. 2018 Mar 09;:
Clin Genitourin Cancer. 2017 Dec 06;:
Curr Oncol. 2017 Dec;24(6):e494-e502
Breast Cancer Res Treat. 2017 Nov 24;:
Clin Genitourin Cancer. 2017 Sep 06;:
Screen Failure Rates in Contemporary Randomized Clinical Phase II/III Therapeutic Trials in Genitourinary Malignancies.
Clin Genitourin Cancer. 2017 Sep 08;:
Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancer.
Ann Oncol. 2017 Oct 01;28(10):2481-2488
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study.
JAMA Oncol. 2017 Aug 17;:e172411
Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis.
Eur Urol Focus. 2017 Jun 03;: